Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s ...

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

FRANKFURT (Reuters) -Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by ...

ZURICH (Reuters) - Roche on Tuesday said it will invest $50 billion in the United States over the next five years, in one of ...

The United States is a key market for the pharmaceutical industry, representing more than half of the revenue of Roche's ...

By Dave Graham ZURICH (Reuters) -Top Swiss officials will this week test whether big commitments to the U.S. can help secure ...

Swiss drugmaker Roche (RHHBY) announced its decision to invest $50 billion in the U.S. towards pharmaceuticals and ...

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...

The Swiss pharma giant said the new positions would include nearly 6,500 in construction and 1,000 at new and expanded ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.